Related Experiment Video

Updated: Jul 14, 2026

Merging Absolute and Relative Quantitative PCR Data to Quantify STAT3 Splice Variant Transcripts
11:19

Merging Absolute and Relative Quantitative PCR Data to Quantify STAT3 Splice Variant Transcripts

Published on: October 9, 2016

Stat3 is tyrosine-phosphorylated through the interleukin-6/glycoprotein 130/Janus kinase pathway in breast cancer

Marjan Berishaj1, Sizhi Paul Gao, Simi Ahmed

  • 1Department of Medicine, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021 USA.

Breast Cancer Research : BCR
|May 29, 2007
PubMed
Abstract

Insights

Constitutive activation of Signal transducer and activator of transcription 3 (Stat3) in breast cancer is primarily driven by the Interleukin-6 (IL-6)/glycoprotein 130 (gp130)/Janus kinase (Jak) pathway, not Src or EGFR. This pathway is crucial for Stat3 phosphorylation and tumor growth.

Area of Science:

  • Oncology
  • Molecular Biology
  • Signal Transduction

Background:

  • Signal transducer and activator of transcription 3 (Stat3) is frequently tyrosine-phosphorylated in breast cancer.
  • Aberrant activation of receptor tyrosine kinases, Src, and Janus kinases (Jaks) are implicated in Stat3 activation in breast cancer.

Purpose of the Study:

  • To investigate the primary mechanisms of Stat3 activation in breast cancer.
  • To determine the role of specific signaling pathways in Stat3 phosphorylation and breast cancer cell growth.

Main Methods:

  • Analysis of Stat3 phosphorylation (pStat3) levels in breast cancer cell lines and primary tumors.
  • Inhibition of Src, EGFR, and Jak kinases.
  • Assessment of the effects of blocking gp130 receptor or IL-6 ligand.
  • Evaluation of conditioned media's effect on Stat3 phosphorylation.

Main Results:

  • Pan-Jak inhibitor P6 abrogated Stat3 phosphorylation and inhibited growth; Src or EGFR inhibition had no effect.
  • Blocking gp130 or sequestering IL-6 reduced pStat3 levels.
  • IL-6 in conditioned media stimulated Stat3 phosphorylation, correlating positively with pStat3 in primary tumors.

Conclusions:

  • The Interleukin-6 (IL-6)/glycoprotein 130 (gp130)/Janus kinase (Jak) pathway is a principal mechanism for Stat3 activation in breast cancer.
  • Targeting this pathway holds potential for breast cancer therapy.

More Related Videos

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...